Bone Biologics Corporation — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c2dfc61-8b87-4560-bfcb-c65996fd8479/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-3.2M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-008564 |
| FY 2024 | $-4.2M | 2024-01-01 – 2024-12-31 | evidence 0001493152-25-008383 |
| FY 2023 | $-9.4M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-007432 |
| FY 2022 | $-3.7M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009799 |
| FY 2021 | $-1.1M | 2021-01-01 – 2021-12-31 | evidence 0001493152-23-009799 |
| FY 2020 | $-825.0k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008887 |
| FY 2019 | $-2.4M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004977 |
| FY 2018 | $-2.8M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004221 |
| FY 2017 | $-2.6M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-004423 |
| FY 2016 | $-20.4M | 2016-01-01 – 2016-12-31 | evidence 0001493152-18-004423 |
| FY 2015 | $-12.0M | 2015-01-01 – 2015-12-31 | evidence 0001493152-16-008297 |
| FY 2014 | $-3.0M | 2014-01-01 – 2014-12-31 | evidence 0001493152-15-001120 |
| FY 2013 | $-672.0k | 2013-01-01 – 2013-12-31 | evidence 0001493152-15-001120 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Bone Biologics Corporation — all facts · Revenue · Net Income